We also found that the hydrogel-supported (ICG-PDT + anti-CTLA4 + anti-PD-L1) treatment had no obvious effects on the myeloid-derived suppressor cells in the tumor (data not shown), which is consistent with the observation of Liu et al. The gene discussed is CTLA4; the disease is neoplasm.